Armata Pharmaceuticals (ARMP) Revenue (2016 - 2018)
Historic Revenue for Armata Pharmaceuticals (ARMP) over the last 6 years, with Q4 2018 value amounting to -$337000.0.
- Armata Pharmaceuticals' Revenue fell 178500.0% to -$337000.0 in Q4 2018 from the same period last year, while for Dec 2018 it was -$925000.0, marking a year-over-year decrease of 90434.78%. This contributed to the annual value of -$5.6 million for FY2024, which is 39259.06% down from last year.
- As of Q4 2018, Armata Pharmaceuticals' Revenue stood at -$337000.0, which was down 178500.0% from -$307000.0 recorded in Q3 2018.
- In the past 5 years, Armata Pharmaceuticals' Revenue ranged from a high of $143000.0 in Q3 2015 and a low of -$337000.0 during Q4 2018
- For the 5-year period, Armata Pharmaceuticals' Revenue averaged around $17578.9, with its median value being $101000.0 (2014).
- In the last 5 years, Armata Pharmaceuticals' Revenue soared by 333333.33% in 2014 and then plummeted by 178500.0% in 2018.
- Over the past 5 years, Armata Pharmaceuticals' Revenue (Quarter) stood at $101000.0 in 2014, then increased by 26.73% to $128000.0 in 2015, then plummeted by 82.81% to $22000.0 in 2016, then dropped by 9.09% to $20000.0 in 2017, then plummeted by 1785.0% to -$337000.0 in 2018.
- Its Revenue was -$337000.0 in Q4 2018, compared to -$307000.0 in Q3 2018 and -$281000.0 in Q2 2018.